Autolus Therapeutics releases 2025 annual report and financial statements
Autolus Therapeutics plc, a Nasdaq-listed biopharmaceutical company, published its annual report and consolidated financial statements for the year ended December 31, 2025. The filing provides comprehensive financial performance data and corporate governance information for the c
View filing at SEC.gov →